| 代码 | 02496 |
|---|---|
| 名称 | 友芝友生物-B |
| 板块 | |
| 公司简介 | Wuhan YZY Biopharma Co Ltd is a China-based company principally engaged in the research, development, production and sales of pharmaceuticals. The Company is mainly engaged in the research, development and industrialization of bispecific antibody drugs. The Company's main products include anti-PD1&anti-CD3, anti-CD19&anti-CD3, and anti-CDX&CD3. The Company's drug products are mainly used in major diseases such as tumor, immunity, inflammation, cardiovascular and infection. |
| 招股价 | HKD 20.00 - 16.00 |
| 面值 | HKD 0.00 |
| 每手股数 | |
| 招股数 | 11001200 |
| 首次公开招股市值 | HKD 176.02(百万) |
| 上市发售股份总数 | 11001200 |
| 配售股份数目 | |
| 公开发售股份数目 | |
| 招股日期 | 2023-09-13 - 2023-09-18 |
| 上市日期 | 2023-09-25 |
| 主要持股人 | |
| 每股股份有形资产净值 | |
| 预测每股备考全面摊薄盈利 | 0.00 |
| 预测加权平均市盈率 | 0.00 |
| 预测备考全面摊薄市盈率 | 0.00 |
| 全球协调人 | |
| 保荐人兼牵头经办人 | |
| 联席保荐人 | |
| 包销商 | |
| 保荐人之法律顾问 | |
| 收款银行 |
- 招股资料